 Lisa Brenner
Concepts (586)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Veterans | 160 | 2026 | 1603 | 23.770 |
Why?
| | Suicide | 62 | 2026 | 720 | 11.930 |
Why?
| | Brain Injuries, Traumatic | 35 | 2026 | 441 | 10.730 |
Why?
| | Military Personnel | 42 | 2026 | 741 | 8.280 |
Why?
| | Brain Injuries | 43 | 2024 | 507 | 8.150 |
Why?
| | Suicidal Ideation | 44 | 2026 | 577 | 7.160 |
Why?
| | Brain Concussion | 30 | 2025 | 640 | 6.840 |
Why?
| | Stress Disorders, Post-Traumatic | 42 | 2025 | 893 | 6.570 |
Why?
| | United States Department of Veterans Affairs | 54 | 2026 | 768 | 6.030 |
Why?
| | Suicide, Attempted | 33 | 2026 | 422 | 5.900 |
Why?
| | Occupational Therapy | 7 | 2026 | 111 | 5.210 |
Why?
| | Mental Disorders | 24 | 2026 | 1168 | 4.430 |
Why?
| | United States | 131 | 2026 | 15966 | 3.750 |
Why?
| | Microbiota | 14 | 2025 | 781 | 3.730 |
Why?
| | Post-Concussion Syndrome | 10 | 2024 | 184 | 2.790 |
Why?
| | Veterans Health | 13 | 2024 | 189 | 2.700 |
Why?
| | Health Services Accessibility | 9 | 2026 | 1098 | 2.680 |
Why?
| | Mental Health | 20 | 2025 | 790 | 2.590 |
Why?
| | Humans | 282 | 2026 | 144759 | 2.550 |
Why?
| | Adult | 146 | 2026 | 40449 | 2.430 |
Why?
| | Blast Injuries | 9 | 2026 | 63 | 2.360 |
Why?
| | Middle Aged | 122 | 2026 | 35875 | 2.220 |
Why?
| | Gastrointestinal Microbiome | 9 | 2025 | 771 | 2.210 |
Why?
| | Male | 164 | 2026 | 72315 | 2.170 |
Why?
| | Female | 167 | 2026 | 78271 | 2.040 |
Why?
| | Iraq War, 2003-2011 | 19 | 2024 | 173 | 2.040 |
Why?
| | Feces | 5 | 2025 | 513 | 1.800 |
Why?
| | Sleep Initiation and Maintenance Disorders | 8 | 2025 | 194 | 1.750 |
Why?
| | Self-Injurious Behavior | 6 | 2020 | 142 | 1.720 |
Why?
| | Toxoplasmosis | 7 | 2025 | 43 | 1.680 |
Why?
| | RNA, Ribosomal, 16S | 5 | 2025 | 558 | 1.660 |
Why?
| | Toxoplasma | 6 | 2025 | 49 | 1.560 |
Why?
| | Activities of Daily Living | 4 | 2025 | 441 | 1.540 |
Why?
| | Firearms | 11 | 2026 | 435 | 1.530 |
Why?
| | Afghan Campaign 2001- | 16 | 2024 | 195 | 1.480 |
Why?
| | Psychological Trauma | 3 | 2022 | 57 | 1.420 |
Why?
| | Safety | 3 | 2026 | 356 | 1.360 |
Why?
| | Aged | 57 | 2026 | 25913 | 1.310 |
Why?
| | Sleep Wake Disorders | 6 | 2025 | 301 | 1.290 |
Why?
| | Brain Injury, Chronic | 4 | 2016 | 25 | 1.270 |
Why?
| | Mobile Applications | 2 | 2025 | 196 | 1.260 |
Why?
| | Qualitative Research | 16 | 2026 | 1671 | 1.230 |
Why?
| | Health Personnel | 3 | 2021 | 748 | 1.210 |
Why?
| | Psychometrics | 11 | 2024 | 734 | 1.200 |
Why?
| | Young Adult | 49 | 2025 | 14105 | 1.190 |
Why?
| | Surveys and Questionnaires | 23 | 2026 | 6048 | 1.180 |
Why?
| | Cerebral Palsy | 3 | 2025 | 132 | 1.080 |
Why?
| | Mental Health Services | 10 | 2024 | 473 | 1.070 |
Why?
| | Healthcare Disparities | 2 | 2025 | 727 | 1.070 |
Why?
| | Inpatients | 7 | 2026 | 545 | 1.010 |
Why?
| | Depressive Disorder | 5 | 2024 | 387 | 1.000 |
Why?
| | Risk Factors | 39 | 2025 | 10779 | 1.000 |
Why?
| | Social Determinants of Health | 2 | 2023 | 301 | 0.990 |
Why?
| | Violence | 6 | 2025 | 281 | 0.990 |
Why?
| | Ambulatory Care | 4 | 2025 | 600 | 0.960 |
Why?
| | Impulsive Behavior | 7 | 2025 | 146 | 0.950 |
Why?
| | Hyperbaric Oxygenation | 3 | 2015 | 39 | 0.920 |
Why?
| | Accidents | 1 | 2026 | 47 | 0.920 |
Why?
| | Health Promotion | 5 | 2019 | 774 | 0.910 |
Why?
| | Cross-Sectional Studies | 24 | 2025 | 5868 | 0.890 |
Why?
| | Antidepressive Agents | 7 | 2025 | 248 | 0.880 |
Why?
| | Reflex, Startle | 1 | 2025 | 76 | 0.880 |
Why?
| | Pandemics | 5 | 2023 | 1694 | 0.870 |
Why?
| | Aftercare | 3 | 2021 | 223 | 0.870 |
Why?
| | Perception | 3 | 2026 | 377 | 0.870 |
Why?
| | Attitude of Health Personnel | 3 | 2026 | 1185 | 0.870 |
Why?
| | Smartphone | 1 | 2025 | 102 | 0.840 |
Why?
| | Patient Discharge | 6 | 2025 | 983 | 0.820 |
Why?
| | Severity of Illness Index | 14 | 2021 | 2925 | 0.820 |
Why?
| | Risk Assessment | 21 | 2026 | 3671 | 0.820 |
Why?
| | Specimen Handling | 1 | 2025 | 186 | 0.800 |
Why?
| | Retrospective Studies | 23 | 2025 | 17066 | 0.790 |
Why?
| | DNA, Bacterial | 2 | 2024 | 342 | 0.780 |
Why?
| | Rural Population | 2 | 2026 | 650 | 0.770 |
Why?
| | Evidence-Based Medicine | 4 | 2023 | 732 | 0.760 |
Why?
| | Mass Screening | 9 | 2025 | 1347 | 0.750 |
Why?
| | Head Injuries, Closed | 1 | 2022 | 49 | 0.740 |
Why?
| | Transition to Adult Care | 1 | 2024 | 96 | 0.730 |
Why?
| | Physical Therapy Specialty | 1 | 2023 | 55 | 0.720 |
Why?
| | Bacteria | 3 | 2025 | 889 | 0.720 |
Why?
| | Probiotics | 2 | 2025 | 61 | 0.710 |
Why?
| | Substance-Related Disorders | 5 | 2023 | 1094 | 0.710 |
Why?
| | Residence Characteristics | 1 | 2025 | 377 | 0.700 |
Why?
| | Personality Assessment | 4 | 2017 | 79 | 0.690 |
Why?
| | Drug Overdose | 2 | 2023 | 370 | 0.690 |
Why?
| | Longitudinal Studies | 15 | 2025 | 2947 | 0.690 |
Why?
| | Nutritional Status | 1 | 2024 | 354 | 0.690 |
Why?
| | Multiple Trauma | 3 | 2025 | 116 | 0.680 |
Why?
| | Sequence Analysis, DNA | 1 | 2024 | 824 | 0.670 |
Why?
| | Psychotherapy | 3 | 2017 | 190 | 0.670 |
Why?
| | Occupational Diseases | 2 | 2020 | 165 | 0.670 |
Why?
| | Cohort Studies | 16 | 2021 | 5960 | 0.660 |
Why?
| | Stroke Rehabilitation | 1 | 2021 | 43 | 0.660 |
Why?
| | Adaptation, Psychological | 8 | 2025 | 717 | 0.640 |
Why?
| | Outpatients | 3 | 2025 | 442 | 0.640 |
Why?
| | Patient Acceptance of Health Care | 5 | 2025 | 885 | 0.640 |
Why?
| | Models, Psychological | 1 | 2022 | 299 | 0.630 |
Why?
| | Disability Evaluation | 6 | 2019 | 310 | 0.620 |
Why?
| | Dysbiosis | 2 | 2018 | 187 | 0.610 |
Why?
| | Spinal Cord Injuries | 2 | 2022 | 240 | 0.610 |
Why?
| | Feasibility Studies | 7 | 2025 | 1095 | 0.600 |
Why?
| | Neuropsychological Tests | 9 | 2024 | 1134 | 0.600 |
Why?
| | Air Pollutants | 1 | 2024 | 438 | 0.580 |
Why?
| | Interviews as Topic | 9 | 2026 | 901 | 0.570 |
Why?
| | Animal Assisted Therapy | 1 | 2018 | 13 | 0.560 |
Why?
| | Porphyromonas gingivalis | 3 | 2025 | 23 | 0.560 |
Why?
| | Pets | 1 | 2018 | 26 | 0.560 |
Why?
| | Caregivers | 2 | 2025 | 1049 | 0.560 |
Why?
| | Antibodies, Protozoan | 5 | 2025 | 41 | 0.560 |
Why?
| | Patient Readmission | 1 | 2024 | 758 | 0.560 |
Why?
| | Death Certificates | 2 | 2023 | 32 | 0.550 |
Why?
| | Adolescent | 23 | 2025 | 22428 | 0.550 |
Why?
| | Sense of Coherence | 1 | 2018 | 12 | 0.550 |
Why?
| | Depression | 7 | 2025 | 1558 | 0.550 |
Why?
| | Hope | 1 | 2018 | 27 | 0.540 |
Why?
| | Hospitalization | 6 | 2025 | 2433 | 0.540 |
Why?
| | Wounds, Gunshot | 5 | 2023 | 258 | 0.540 |
Why?
| | Hospitals, Veterans | 7 | 2022 | 259 | 0.530 |
Why?
| | Child Development | 1 | 2022 | 484 | 0.530 |
Why?
| | Triage | 1 | 2020 | 249 | 0.520 |
Why?
| | Social Support | 6 | 2025 | 652 | 0.520 |
Why?
| | Emotions | 2 | 2025 | 578 | 0.520 |
Why?
| | Risk | 5 | 2023 | 911 | 0.520 |
Why?
| | Drug Packaging | 1 | 2017 | 41 | 0.510 |
Why?
| | Psychotherapy, Group | 1 | 2017 | 80 | 0.500 |
Why?
| | Child Abuse | 1 | 2022 | 551 | 0.490 |
Why?
| | Cognition Disorders | 3 | 2014 | 538 | 0.490 |
Why?
| | Machine Learning | 5 | 2025 | 585 | 0.480 |
Why?
| | Problem Solving | 1 | 2017 | 156 | 0.480 |
Why?
| | Protective Factors | 2 | 2015 | 99 | 0.480 |
Why?
| | Executive Function | 4 | 2017 | 461 | 0.480 |
Why?
| | Parkinson Disease | 1 | 2022 | 600 | 0.470 |
Why?
| | Inflammation | 7 | 2022 | 2878 | 0.470 |
Why?
| | Self Report | 7 | 2026 | 872 | 0.470 |
Why?
| | Home Care Services | 1 | 2019 | 280 | 0.470 |
Why?
| | Headache | 3 | 2022 | 150 | 0.460 |
Why?
| | Postural Balance | 1 | 2018 | 240 | 0.460 |
Why?
| | Sleep Apnea, Obstructive | 3 | 2024 | 300 | 0.450 |
Why?
| | Cause of Death | 2 | 2023 | 471 | 0.450 |
Why?
| | Patient Care Team | 3 | 2024 | 689 | 0.450 |
Why?
| | Sex Factors | 8 | 2025 | 2112 | 0.450 |
Why?
| | Comorbidity | 10 | 2025 | 1658 | 0.440 |
Why?
| | Pneumonia, Viral | 1 | 2020 | 384 | 0.440 |
Why?
| | Coronavirus Infections | 1 | 2020 | 378 | 0.440 |
Why?
| | Immunoglobulin G | 6 | 2025 | 893 | 0.430 |
Why?
| | Afghanistan | 3 | 2024 | 96 | 0.430 |
Why?
| | Reproducibility of Results | 10 | 2024 | 3409 | 0.420 |
Why?
| | Combat Disorders | 2 | 2017 | 43 | 0.420 |
Why?
| | Psychiatric Status Rating Scales | 7 | 2025 | 541 | 0.410 |
Why?
| | Hypertension | 1 | 2022 | 1263 | 0.400 |
Why?
| | Case-Control Studies | 8 | 2022 | 3604 | 0.390 |
Why?
| | Health Planning | 1 | 2013 | 48 | 0.390 |
Why?
| | Iraq | 2 | 2024 | 66 | 0.390 |
Why?
| | Neuropsychology | 2 | 2011 | 42 | 0.390 |
Why?
| | Recovery of Function | 5 | 2024 | 707 | 0.390 |
Why?
| | Quality Improvement | 2 | 2020 | 1289 | 0.390 |
Why?
| | Risk Management | 1 | 2014 | 84 | 0.390 |
Why?
| | Aggression | 5 | 2025 | 179 | 0.390 |
Why?
| | Prevalence | 11 | 2026 | 2834 | 0.380 |
Why?
| | Medication Adherence | 1 | 2017 | 539 | 0.380 |
Why?
| | Observational Studies as Topic | 2 | 2024 | 129 | 0.370 |
Why?
| | Anxiety Disorders | 1 | 2016 | 373 | 0.370 |
Why?
| | Trauma Severity Indices | 5 | 2019 | 112 | 0.370 |
Why?
| | Athletic Injuries | 1 | 2019 | 569 | 0.370 |
Why?
| | Interpersonal Relations | 1 | 2015 | 400 | 0.360 |
Why?
| | Stress, Physiological | 1 | 2015 | 453 | 0.350 |
Why?
| | Health Services Needs and Demand | 2 | 2025 | 280 | 0.350 |
Why?
| | Colorado | 6 | 2024 | 4564 | 0.340 |
Why?
| | Telemedicine | 1 | 2020 | 945 | 0.330 |
Why?
| | Quality of Life | 5 | 2019 | 3185 | 0.330 |
Why?
| | Emergency Service, Hospital | 7 | 2026 | 2310 | 0.330 |
Why?
| | Post-Traumatic Headache | 2 | 2020 | 5 | 0.320 |
Why?
| | Ethanol | 3 | 2024 | 627 | 0.320 |
Why?
| | Aged, 80 and over | 7 | 2021 | 8265 | 0.320 |
Why?
| | Bayes Theorem | 2 | 2022 | 433 | 0.320 |
Why?
| | Socioeconomic Factors | 6 | 2023 | 1326 | 0.320 |
Why?
| | Sex Offenses | 2 | 2023 | 196 | 0.310 |
Why?
| | United States Department of Defense | 2 | 2025 | 21 | 0.310 |
Why?
| | Tryptophan | 3 | 2022 | 181 | 0.300 |
Why?
| | Wounds and Injuries | 1 | 2018 | 956 | 0.300 |
Why?
| | Nervous System Diseases | 2 | 2025 | 284 | 0.300 |
Why?
| | Terminology as Topic | 1 | 2011 | 255 | 0.290 |
Why?
| | Randomized Controlled Trials as Topic | 4 | 2024 | 1720 | 0.290 |
Why?
| | Diagnostic Imaging | 2 | 2011 | 338 | 0.290 |
Why?
| | Crisis Intervention | 3 | 2024 | 38 | 0.290 |
Why?
| | Amish | 2 | 2019 | 7 | 0.280 |
Why?
| | Housing | 2 | 2020 | 144 | 0.280 |
Why?
| | Quality of Health Care | 1 | 2013 | 691 | 0.280 |
Why?
| | Public Health | 5 | 2022 | 566 | 0.280 |
Why?
| | Program Evaluation | 3 | 2024 | 948 | 0.280 |
Why?
| | Dizziness | 2 | 2019 | 101 | 0.280 |
Why?
| | Stress, Psychological | 2 | 2020 | 1152 | 0.270 |
Why?
| | Intention | 1 | 2009 | 183 | 0.270 |
Why?
| | Pregnancy Trimester, First | 2 | 2025 | 136 | 0.260 |
Why?
| | Kynurenine | 3 | 2018 | 114 | 0.260 |
Why?
| | Neuropsychiatry | 2 | 2020 | 17 | 0.250 |
Why?
| | Cognitive Dysfunction | 1 | 2013 | 461 | 0.250 |
Why?
| | Sleep | 3 | 2024 | 901 | 0.250 |
Why?
| | Age Factors | 6 | 2024 | 3333 | 0.250 |
Why?
| | Health Behavior | 1 | 2012 | 785 | 0.250 |
Why?
| | Emergency Medical Services | 2 | 2023 | 696 | 0.240 |
Why?
| | Environment, Controlled | 2 | 2016 | 23 | 0.240 |
Why?
| | Hotlines | 4 | 2024 | 32 | 0.240 |
Why?
| | Oregon | 1 | 2026 | 76 | 0.230 |
Why?
| | Factor Analysis, Statistical | 4 | 2024 | 293 | 0.230 |
Why?
| | New Mexico | 1 | 2026 | 99 | 0.230 |
Why?
| | Central Nervous System | 2 | 2025 | 281 | 0.230 |
Why?
| | Time Factors | 7 | 2019 | 7173 | 0.230 |
Why?
| | Decision Support Techniques | 2 | 2025 | 456 | 0.230 |
Why?
| | Prospective Studies | 10 | 2025 | 7990 | 0.230 |
Why?
| | Follow-Up Studies | 5 | 2022 | 5408 | 0.230 |
Why?
| | Treatment Outcome | 11 | 2022 | 11679 | 0.230 |
Why?
| | Rehabilitation Research | 1 | 2025 | 7 | 0.230 |
Why?
| | Rehabilitation Centers | 2 | 2024 | 39 | 0.220 |
Why?
| | Common Data Elements | 1 | 2025 | 15 | 0.220 |
Why?
| | Neurological Rehabilitation | 1 | 2025 | 12 | 0.220 |
Why?
| | Motivation | 1 | 2009 | 610 | 0.220 |
Why?
| | Drug Storage | 1 | 2025 | 53 | 0.220 |
Why?
| | Social Participation | 1 | 2025 | 29 | 0.220 |
Why?
| | Social Environment | 1 | 2026 | 254 | 0.210 |
Why?
| | Antibodies, Bacterial | 1 | 2025 | 148 | 0.210 |
Why?
| | Delay Discounting | 1 | 2024 | 29 | 0.210 |
Why?
| | tau Proteins | 1 | 2025 | 115 | 0.210 |
Why?
| | Policy | 2 | 2022 | 146 | 0.210 |
Why?
| | Logistic Models | 7 | 2025 | 2117 | 0.210 |
Why?
| | Affect | 2 | 2018 | 318 | 0.210 |
Why?
| | Lomustine | 1 | 2024 | 15 | 0.210 |
Why?
| | Complementary Therapies | 2 | 2016 | 94 | 0.210 |
Why?
| | Primary Health Care | 2 | 2025 | 1733 | 0.210 |
Why?
| | Decision Making | 3 | 2024 | 975 | 0.210 |
Why?
| | Patient Health Questionnaire | 1 | 2024 | 41 | 0.210 |
Why?
| | Mouth | 1 | 2024 | 88 | 0.200 |
Why?
| | Sensitivity and Specificity | 4 | 2013 | 1985 | 0.200 |
Why?
| | Metals, Heavy | 1 | 2024 | 31 | 0.200 |
Why?
| | Sex Distribution | 2 | 2023 | 386 | 0.200 |
Why?
| | Anxiety | 4 | 2025 | 1109 | 0.200 |
Why?
| | Pesticides | 1 | 2024 | 63 | 0.200 |
Why?
| | Irritable Bowel Syndrome | 1 | 2023 | 29 | 0.200 |
Why?
| | Natural Language Processing | 1 | 2025 | 103 | 0.200 |
Why?
| | Wildfires | 1 | 2024 | 42 | 0.190 |
Why?
| | Prognosis | 3 | 2024 | 4282 | 0.190 |
Why?
| | Global Burden of Disease | 1 | 2023 | 23 | 0.190 |
Why?
| | Psychiatric Department, Hospital | 2 | 2014 | 12 | 0.190 |
Why?
| | Clinical Protocols | 2 | 2015 | 282 | 0.190 |
Why?
| | Prednisone | 1 | 2024 | 221 | 0.190 |
Why?
| | Abruptio Placentae | 1 | 2022 | 6 | 0.190 |
Why?
| | Transportation of Patients | 1 | 2023 | 68 | 0.190 |
Why?
| | Rats, Sprague-Dawley | 2 | 2025 | 2527 | 0.190 |
Why?
| | Disaster Planning | 1 | 2024 | 102 | 0.190 |
Why?
| | Disasters | 1 | 2024 | 102 | 0.190 |
Why?
| | Interview, Psychological | 2 | 2015 | 94 | 0.190 |
Why?
| | Ohio | 1 | 2022 | 145 | 0.180 |
Why?
| | Pharmacogenomic Testing | 1 | 2022 | 62 | 0.180 |
Why?
| | Schizophrenia | 2 | 2016 | 446 | 0.180 |
Why?
| | Biomarkers | 4 | 2026 | 4271 | 0.180 |
Why?
| | Inappropriate Prescribing | 1 | 2022 | 63 | 0.170 |
Why?
| | Neopterin | 2 | 2022 | 13 | 0.170 |
Why?
| | Meta-Analysis as Topic | 1 | 2022 | 174 | 0.170 |
Why?
| | Incidence | 6 | 2019 | 2879 | 0.170 |
Why?
| | Subacute Care | 1 | 2022 | 82 | 0.170 |
Why?
| | Health Knowledge, Attitudes, Practice | 2 | 2024 | 1414 | 0.170 |
Why?
| | Physician-Patient Relations | 2 | 2025 | 585 | 0.170 |
Why?
| | Hepatic Encephalopathy | 1 | 2021 | 25 | 0.170 |
Why?
| | Drug Interactions | 1 | 2022 | 398 | 0.170 |
Why?
| | Guideline Adherence | 1 | 2025 | 589 | 0.170 |
Why?
| | High-Throughput Nucleotide Sequencing | 1 | 2024 | 549 | 0.160 |
Why?
| | Pregnancy Complications, Infectious | 1 | 2025 | 428 | 0.160 |
Why?
| | Cost of Illness | 1 | 2023 | 321 | 0.160 |
Why?
| | Skin | 2 | 2023 | 755 | 0.160 |
Why?
| | Pilot Projects | 5 | 2024 | 1886 | 0.160 |
Why?
| | Frailty | 1 | 2024 | 198 | 0.160 |
Why?
| | Burns | 1 | 2025 | 377 | 0.160 |
Why?
| | Skilled Nursing Facilities | 1 | 2022 | 151 | 0.160 |
Why?
| | Parenting | 1 | 2024 | 318 | 0.160 |
Why?
| | Anger | 3 | 2021 | 60 | 0.160 |
Why?
| | Diagnostic and Statistical Manual of Mental Disorders | 4 | 2016 | 232 | 0.160 |
Why?
| | Hawaii | 3 | 2026 | 46 | 0.160 |
Why?
| | HIV Infections | 1 | 2015 | 3154 | 0.160 |
Why?
| | Proteome | 1 | 2025 | 518 | 0.160 |
Why?
| | Air Pollution | 1 | 2024 | 327 | 0.160 |
Why?
| | Seasonal Affective Disorder | 1 | 2020 | 9 | 0.160 |
Why?
| | Amyotrophic Lateral Sclerosis | 1 | 2021 | 99 | 0.150 |
Why?
| | Receptors, Calcitriol | 1 | 2020 | 55 | 0.150 |
Why?
| | Sex Characteristics | 1 | 2025 | 790 | 0.150 |
Why?
| | Hyperacusis | 1 | 2019 | 8 | 0.150 |
Why?
| | Rats | 2 | 2025 | 5597 | 0.150 |
Why?
| | Photophobia | 1 | 2019 | 13 | 0.150 |
Why?
| | Hypesthesia | 1 | 2019 | 21 | 0.150 |
Why?
| | Environment Design | 2 | 2016 | 27 | 0.150 |
Why?
| | Vitamin D Deficiency | 1 | 2021 | 186 | 0.150 |
Why?
| | Survival Analysis | 3 | 2011 | 1382 | 0.150 |
Why?
| | Communicable Diseases | 1 | 2022 | 163 | 0.150 |
Why?
| | Pregnancy Complications | 1 | 2025 | 592 | 0.150 |
Why?
| | Paresis | 1 | 2019 | 30 | 0.150 |
Why?
| | Periodontitis | 1 | 2020 | 54 | 0.150 |
Why?
| | Arm Injuries | 1 | 2019 | 24 | 0.150 |
Why?
| | Environmental Exposure | 1 | 2024 | 588 | 0.150 |
Why?
| | Chronic Traumatic Encephalopathy | 1 | 2019 | 17 | 0.150 |
Why?
| | Morals | 1 | 2020 | 80 | 0.150 |
Why?
| | Hippocampus | 1 | 2025 | 965 | 0.150 |
Why?
| | Odds Ratio | 5 | 2016 | 1075 | 0.150 |
Why?
| | Occupational Injuries | 1 | 2019 | 46 | 0.150 |
Why?
| | Medical Staff, Hospital | 1 | 2019 | 80 | 0.140 |
Why?
| | Inflammatory Bowel Diseases | 1 | 2023 | 365 | 0.140 |
Why?
| | Alcoholism | 2 | 2024 | 817 | 0.140 |
Why?
| | Environmental Microbiology | 1 | 2019 | 57 | 0.140 |
Why?
| | Patient-Centered Care | 1 | 2024 | 544 | 0.140 |
Why?
| | Arm | 1 | 2019 | 109 | 0.140 |
Why?
| | Liver Cirrhosis | 1 | 2021 | 288 | 0.140 |
Why?
| | Delirium | 2 | 2011 | 104 | 0.140 |
Why?
| | Premature Birth | 1 | 2022 | 380 | 0.140 |
Why?
| | Women's Health | 1 | 2021 | 310 | 0.140 |
Why?
| | Diet | 2 | 2023 | 1273 | 0.140 |
Why?
| | Health Services Research | 1 | 2021 | 396 | 0.140 |
Why?
| | Fatigue | 2 | 2018 | 366 | 0.140 |
Why?
| | Psychotherapy, Brief | 1 | 2018 | 41 | 0.140 |
Why?
| | Food Supply | 1 | 2019 | 90 | 0.140 |
Why?
| | Cross-Over Studies | 2 | 2018 | 601 | 0.140 |
Why?
| | Reproductive Health | 3 | 2024 | 91 | 0.140 |
Why?
| | Adiponectin | 1 | 2020 | 244 | 0.130 |
Why?
| | Phenylalanine | 1 | 2018 | 71 | 0.130 |
Why?
| | Child | 5 | 2024 | 22633 | 0.130 |
Why?
| | Tyrosine | 1 | 2018 | 222 | 0.130 |
Why?
| | Dogs | 1 | 2018 | 437 | 0.130 |
Why?
| | Confidence Intervals | 3 | 2016 | 333 | 0.130 |
Why?
| | Prebiotics | 1 | 2017 | 28 | 0.130 |
Why?
| | Prefrontal Cortex | 2 | 2017 | 328 | 0.130 |
Why?
| | Gliadin | 1 | 2016 | 13 | 0.130 |
Why?
| | Electronic Health Records | 1 | 2025 | 1173 | 0.120 |
Why?
| | Amygdala | 2 | 2017 | 198 | 0.120 |
Why?
| | Patient Selection | 1 | 2020 | 719 | 0.120 |
Why?
| | Housing, Animal | 1 | 2016 | 46 | 0.120 |
Why?
| | Disease Models, Animal | 2 | 2017 | 4557 | 0.120 |
Why?
| | Databases, Factual | 1 | 2022 | 1486 | 0.120 |
Why?
| | Physical Therapy Modalities | 1 | 2019 | 332 | 0.120 |
Why?
| | Social Work, Psychiatric | 1 | 2015 | 3 | 0.120 |
Why?
| | Community Mental Health Centers | 1 | 2015 | 14 | 0.120 |
Why?
| | Immunomodulation | 1 | 2016 | 101 | 0.120 |
Why?
| | Neuroimaging | 2 | 2017 | 289 | 0.110 |
Why?
| | Animals | 7 | 2025 | 38058 | 0.110 |
Why?
| | Obesity | 2 | 2019 | 3077 | 0.110 |
Why?
| | Medical Records | 1 | 2016 | 187 | 0.110 |
Why?
| | Actigraphy | 1 | 2016 | 145 | 0.110 |
Why?
| | Prescription Drug Misuse | 1 | 2015 | 51 | 0.110 |
Why?
| | Health Status Indicators | 2 | 2012 | 166 | 0.110 |
Why?
| | Delivery of Health Care | 4 | 2023 | 947 | 0.110 |
Why?
| | Counseling | 2 | 2023 | 408 | 0.110 |
Why?
| | Israel | 2 | 2025 | 46 | 0.110 |
Why?
| | Propylamines | 1 | 2014 | 11 | 0.110 |
Why?
| | Adrenergic Uptake Inhibitors | 1 | 2014 | 14 | 0.110 |
Why?
| | Guam | 2 | 2025 | 16 | 0.110 |
Why?
| | Needs Assessment | 2 | 2024 | 404 | 0.100 |
Why?
| | Thalamus | 1 | 2015 | 125 | 0.100 |
Why?
| | Analgesics, Opioid | 1 | 2023 | 1143 | 0.100 |
Why?
| | Mood Disorders | 1 | 2015 | 140 | 0.100 |
Why?
| | Cross-Cultural Comparison | 1 | 2014 | 84 | 0.100 |
Why?
| | Forecasting | 1 | 2016 | 391 | 0.100 |
Why?
| | Biomedical Research | 1 | 2020 | 710 | 0.100 |
Why?
| | Genes, p53 | 1 | 1993 | 67 | 0.100 |
Why?
| | Cerebellum | 1 | 2015 | 223 | 0.100 |
Why?
| | Analgesics | 1 | 2015 | 228 | 0.100 |
Why?
| | Forensic Psychiatry | 1 | 2013 | 29 | 0.100 |
Why?
| | Australia | 1 | 2014 | 286 | 0.100 |
Why?
| | Chi-Square Distribution | 2 | 2011 | 529 | 0.100 |
Why?
| | Self Concept | 1 | 2015 | 253 | 0.100 |
Why?
| | Burnout, Professional | 1 | 2020 | 484 | 0.100 |
Why?
| | Seroepidemiologic Studies | 3 | 2019 | 172 | 0.100 |
Why?
| | Percutaneous Coronary Intervention | 1 | 2019 | 543 | 0.100 |
Why?
| | Patient Satisfaction | 1 | 2017 | 704 | 0.100 |
Why?
| | Stress Disorders, Traumatic | 1 | 2013 | 24 | 0.100 |
Why?
| | Linear Models | 3 | 2010 | 854 | 0.090 |
Why?
| | Employment | 1 | 2014 | 188 | 0.090 |
Why?
| | Sex | 1 | 2012 | 4 | 0.090 |
Why?
| | Multivariate Analysis | 2 | 2019 | 1539 | 0.090 |
Why?
| | Coronary Artery Disease | 1 | 2019 | 741 | 0.090 |
Why?
| | Computer Communication Networks | 1 | 2012 | 32 | 0.090 |
Why?
| | Football | 1 | 2013 | 89 | 0.090 |
Why?
| | Brain | 4 | 2021 | 2933 | 0.090 |
Why?
| | Advisory Committees | 1 | 2013 | 228 | 0.090 |
Why?
| | Decision Support Systems, Clinical | 1 | 2016 | 265 | 0.090 |
Why?
| | Algorithms | 3 | 2019 | 1837 | 0.090 |
Why?
| | Task Performance and Analysis | 2 | 2017 | 198 | 0.090 |
Why?
| | Therapy, Computer-Assisted | 1 | 2012 | 64 | 0.090 |
Why?
| | Statistics, Nonparametric | 2 | 2009 | 427 | 0.090 |
Why?
| | Infant | 2 | 2022 | 10034 | 0.090 |
Why?
| | Information Dissemination | 1 | 2013 | 223 | 0.090 |
Why?
| | Signal Transduction | 1 | 2025 | 5226 | 0.080 |
Why?
| | Ethics, Professional | 1 | 2011 | 13 | 0.080 |
Why?
| | Consciousness Disorders | 1 | 2011 | 23 | 0.080 |
Why?
| | Social Stigma | 1 | 2013 | 171 | 0.080 |
Why?
| | Interprofessional Relations | 1 | 2013 | 281 | 0.080 |
Why?
| | Transforming Growth Factor beta | 1 | 1993 | 479 | 0.080 |
Why?
| | Life Change Events | 1 | 2012 | 147 | 0.080 |
Why?
| | Walking | 1 | 2015 | 545 | 0.080 |
Why?
| | Psychomotor Agitation | 1 | 2011 | 70 | 0.080 |
Why?
| | Pregnancy | 4 | 2025 | 7190 | 0.080 |
Why?
| | Inservice Training | 1 | 2011 | 117 | 0.080 |
Why?
| | Predictive Value of Tests | 2 | 2019 | 2115 | 0.080 |
Why?
| | Research | 1 | 2013 | 431 | 0.080 |
Why?
| | Health Policy | 1 | 2013 | 400 | 0.080 |
Why?
| | Health Plan Implementation | 1 | 2011 | 136 | 0.080 |
Why?
| | Life Style | 1 | 2012 | 479 | 0.080 |
Why?
| | Glucose | 1 | 2015 | 1047 | 0.080 |
Why?
| | Diffusion Magnetic Resonance Imaging | 1 | 2011 | 154 | 0.080 |
Why?
| | Attention Deficit Disorder with Hyperactivity | 1 | 2014 | 428 | 0.080 |
Why?
| | Interdisciplinary Communication | 1 | 2011 | 197 | 0.080 |
Why?
| | Multiple Sclerosis | 1 | 2015 | 484 | 0.080 |
Why?
| | Irritable Mood | 2 | 2021 | 50 | 0.080 |
Why?
| | Analysis of Variance | 2 | 2011 | 1306 | 0.080 |
Why?
| | Explosions | 1 | 2009 | 15 | 0.080 |
Why?
| | Religion and Psychology | 1 | 2009 | 27 | 0.080 |
Why?
| | Diagnosis, Differential | 1 | 2014 | 1489 | 0.080 |
Why?
| | HIV-1 | 1 | 2015 | 896 | 0.070 |
Why?
| | Data Collection | 1 | 2012 | 633 | 0.070 |
Why?
| | Affective Symptoms | 1 | 2009 | 53 | 0.070 |
Why?
| | Elective Surgical Procedures | 1 | 2011 | 201 | 0.070 |
Why?
| | Patient Education as Topic | 1 | 2014 | 780 | 0.070 |
Why?
| | Neurologic Examination | 1 | 2009 | 131 | 0.070 |
Why?
| | Carcinoma, Squamous Cell | 1 | 1993 | 641 | 0.070 |
Why?
| | Hypogonadism | 1 | 2009 | 90 | 0.070 |
Why?
| | Cooperative Behavior | 1 | 2011 | 465 | 0.070 |
Why?
| | Proportional Hazards Models | 1 | 2011 | 1325 | 0.070 |
Why?
| | Population Surveillance | 1 | 2011 | 485 | 0.070 |
Why?
| | Alcohol Drinking | 1 | 2014 | 826 | 0.070 |
Why?
| | Brain Mapping | 1 | 2011 | 536 | 0.070 |
Why?
| | Resilience, Psychological | 1 | 2009 | 152 | 0.060 |
Why?
| | Language Disorders | 1 | 2007 | 29 | 0.060 |
Why?
| | Glasgow Coma Scale | 3 | 2014 | 213 | 0.060 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 2 | 2019 | 851 | 0.060 |
Why?
| | Claudin-3 | 1 | 2026 | 3 | 0.060 |
Why?
| | Puerto Rico | 1 | 2026 | 58 | 0.060 |
Why?
| | Healthy Volunteers | 2 | 2018 | 215 | 0.060 |
Why?
| | Psychological Tests | 1 | 2007 | 132 | 0.060 |
Why?
| | Aging | 1 | 2017 | 1966 | 0.060 |
Why?
| | Orthotic Devices | 1 | 2025 | 26 | 0.060 |
Why?
| | Permeability | 1 | 2026 | 168 | 0.060 |
Why?
| | Fatty Acid-Binding Proteins | 1 | 2026 | 79 | 0.060 |
Why?
| | American Samoa | 1 | 2025 | 6 | 0.060 |
Why?
| | Micronesia | 1 | 2025 | 7 | 0.060 |
Why?
| | Hostility | 1 | 2025 | 16 | 0.060 |
Why?
| | National Institute of Neurological Disorders and Stroke (U.S.) | 1 | 2025 | 6 | 0.060 |
Why?
| | Firefighters | 1 | 2026 | 47 | 0.060 |
Why?
| | Serogroup | 1 | 2025 | 44 | 0.060 |
Why?
| | Ubiquitin Thiolesterase | 1 | 2025 | 68 | 0.060 |
Why?
| | Glial Fibrillary Acidic Protein | 1 | 2025 | 124 | 0.060 |
Why?
| | Neurofilament Proteins | 1 | 2025 | 78 | 0.060 |
Why?
| | Testosterone | 1 | 2009 | 419 | 0.050 |
Why?
| | Armed Conflicts | 1 | 2025 | 15 | 0.050 |
Why?
| | Terrorism | 1 | 2024 | 29 | 0.050 |
Why?
| | Reproductive Health Services | 1 | 2024 | 18 | 0.050 |
Why?
| | Transcranial Magnetic Stimulation | 1 | 2024 | 64 | 0.050 |
Why?
| | Magnetic Resonance Imaging | 2 | 2024 | 3863 | 0.050 |
Why?
| | Diffusion Tensor Imaging | 1 | 2024 | 73 | 0.050 |
Why?
| | Social Change | 1 | 2024 | 14 | 0.050 |
Why?
| | Documentation | 1 | 2026 | 198 | 0.050 |
Why?
| | Treatment Adherence and Compliance | 1 | 2024 | 27 | 0.050 |
Why?
| | Warfare | 1 | 2025 | 101 | 0.050 |
Why?
| | Comparative Effectiveness Research | 1 | 2025 | 170 | 0.050 |
Why?
| | Length of Stay | 1 | 2009 | 1337 | 0.050 |
Why?
| | Asphyxia | 1 | 2023 | 23 | 0.050 |
Why?
| | Video Recording | 1 | 2024 | 212 | 0.050 |
Why?
| | Frontal Lobe | 1 | 2024 | 160 | 0.050 |
Why?
| | Friends | 1 | 2023 | 56 | 0.050 |
Why?
| | Choice Behavior | 1 | 2024 | 177 | 0.050 |
Why?
| | Fertility | 1 | 2024 | 168 | 0.050 |
Why?
| | Cognition | 2 | 2022 | 1266 | 0.050 |
Why?
| | Immunoglobulin M | 1 | 2024 | 284 | 0.050 |
Why?
| | Administration, Oral | 1 | 2025 | 847 | 0.050 |
Why?
| | Antineoplastic Combined Chemotherapy Protocols | 1 | 2012 | 1953 | 0.050 |
Why?
| | Stillbirth | 1 | 2022 | 77 | 0.040 |
Why?
| | Public Opinion | 1 | 2022 | 60 | 0.040 |
Why?
| | Remission Induction | 1 | 2022 | 307 | 0.040 |
Why?
| | Ownership | 1 | 2022 | 111 | 0.040 |
Why?
| | Disease Susceptibility | 1 | 2023 | 348 | 0.040 |
Why?
| | Social Justice | 1 | 2022 | 86 | 0.040 |
Why?
| | Pharmacogenetics | 1 | 2022 | 172 | 0.040 |
Why?
| | Research Report | 1 | 2021 | 87 | 0.040 |
Why?
| | Nursing Homes | 1 | 2022 | 172 | 0.040 |
Why?
| | Cathelicidins | 1 | 2020 | 41 | 0.040 |
Why?
| | Postoperative Complications | 2 | 2011 | 2919 | 0.040 |
Why?
| | Lithium Compounds | 1 | 2019 | 11 | 0.040 |
Why?
| | Internet | 1 | 2024 | 699 | 0.040 |
Why?
| | Patient Compliance | 1 | 2024 | 588 | 0.040 |
Why?
| | Double-Blind Method | 2 | 2015 | 2029 | 0.040 |
Why?
| | Antimicrobial Cationic Peptides | 1 | 2020 | 86 | 0.040 |
Why?
| | Breast Neoplasms | 1 | 2012 | 2452 | 0.040 |
Why?
| | September 11 Terrorist Attacks | 1 | 2019 | 31 | 0.040 |
Why?
| | Clinical Decision-Making | 1 | 2022 | 359 | 0.040 |
Why?
| | Retirement | 1 | 2019 | 35 | 0.040 |
Why?
| | Disease Progression | 2 | 2017 | 2847 | 0.040 |
Why?
| | Research Design | 2 | 2015 | 1135 | 0.030 |
Why?
| | Serologic Tests | 1 | 2018 | 53 | 0.030 |
Why?
| | Ketamine | 1 | 2019 | 132 | 0.030 |
Why?
| | Attitude | 1 | 2020 | 260 | 0.030 |
Why?
| | Proteomics | 1 | 2025 | 1195 | 0.030 |
Why?
| | Wakefulness | 1 | 2019 | 169 | 0.030 |
Why?
| | Patient Preference | 1 | 2020 | 224 | 0.030 |
Why?
| | Germany | 1 | 2018 | 138 | 0.030 |
Why?
| | Memory Disorders | 1 | 2019 | 193 | 0.030 |
Why?
| | Nutrition Surveys | 1 | 2019 | 282 | 0.030 |
Why?
| | Epigenesis, Genetic | 1 | 2022 | 684 | 0.030 |
Why?
| | Seasons | 1 | 2020 | 556 | 0.030 |
Why?
| | RNA, Bacterial | 1 | 2017 | 189 | 0.030 |
Why?
| | War-Related Injuries | 1 | 2017 | 46 | 0.030 |
Why?
| | Behavioral Risk Factor Surveillance System | 1 | 2016 | 59 | 0.030 |
Why?
| | Organ Size | 1 | 2017 | 463 | 0.030 |
Why?
| | Combined Modality Therapy | 1 | 2019 | 1266 | 0.030 |
Why?
| | Sick Building Syndrome | 1 | 2015 | 4 | 0.030 |
Why?
| | Behavior Therapy | 1 | 2019 | 299 | 0.030 |
Why?
| | Dopamine Antagonists | 1 | 1996 | 25 | 0.030 |
Why?
| | Receptors, Dopamine | 1 | 1996 | 19 | 0.030 |
Why?
| | Referral and Consultation | 1 | 2022 | 851 | 0.030 |
Why?
| | Practice Patterns, Physicians' | 1 | 2025 | 1356 | 0.030 |
Why?
| | Chromatography, High Pressure Liquid | 1 | 2018 | 594 | 0.030 |
Why?
| | Placenta | 1 | 2022 | 780 | 0.030 |
Why?
| | Tomography, Emission-Computed, Single-Photon | 1 | 1996 | 103 | 0.030 |
Why?
| | Dopamine | 1 | 2018 | 283 | 0.030 |
Why?
| | Iodine Radioisotopes | 1 | 1996 | 136 | 0.030 |
Why?
| | Psychological Techniques | 1 | 2014 | 8 | 0.030 |
Why?
| | Environment | 1 | 2017 | 305 | 0.030 |
Why?
| | Poverty | 1 | 2019 | 529 | 0.030 |
Why?
| | Pyrrolidines | 1 | 1996 | 125 | 0.030 |
Why?
| | Reward | 1 | 2017 | 247 | 0.030 |
Why?
| | Gene Expression | 1 | 2020 | 1490 | 0.030 |
Why?
| | Atomoxetine Hydrochloride | 1 | 2014 | 8 | 0.030 |
Why?
| | Community Mental Health Services | 1 | 2015 | 86 | 0.030 |
Why?
| | Benzamides | 1 | 1996 | 224 | 0.030 |
Why?
| | Radiopharmaceuticals | 1 | 2015 | 194 | 0.030 |
Why?
| | Fluorodeoxyglucose F18 | 1 | 2015 | 156 | 0.030 |
Why?
| | Florida | 1 | 2014 | 117 | 0.030 |
Why?
| | Body Weight | 1 | 2019 | 976 | 0.030 |
Why?
| | Risk-Taking | 1 | 2017 | 328 | 0.030 |
Why?
| | Positron-Emission Tomography | 1 | 2015 | 323 | 0.030 |
Why?
| | Antipsychotic Agents | 1 | 1996 | 213 | 0.030 |
Why?
| | Health Surveys | 1 | 2015 | 518 | 0.020 |
Why?
| | Drug Resistance | 1 | 1993 | 153 | 0.020 |
Why?
| | Piperazines | 1 | 1996 | 381 | 0.020 |
Why?
| | Personality | 1 | 2014 | 132 | 0.020 |
Why?
| | Genome-Wide Association Study | 1 | 2019 | 1406 | 0.020 |
Why?
| | Suramin | 1 | 2012 | 7 | 0.020 |
Why?
| | Pain Measurement | 1 | 2015 | 552 | 0.020 |
Why?
| | Exercise Test | 1 | 2015 | 634 | 0.020 |
Why?
| | Leukopenia | 1 | 2012 | 33 | 0.020 |
Why?
| | Focus Groups | 1 | 2015 | 573 | 0.020 |
Why?
| | Genetic Vectors | 1 | 1993 | 337 | 0.020 |
Why?
| | Taxoids | 1 | 2012 | 116 | 0.020 |
Why?
| | Tumor Cells, Cultured | 1 | 1993 | 919 | 0.020 |
Why?
| | Fibroblast Growth Factor 2 | 1 | 2012 | 93 | 0.020 |
Why?
| | Health Priorities | 1 | 2012 | 42 | 0.020 |
Why?
| | Dose-Response Relationship, Drug | 2 | 2012 | 2027 | 0.020 |
Why?
| | Nausea | 1 | 2012 | 111 | 0.020 |
Why?
| | Statistics as Topic | 1 | 2012 | 284 | 0.020 |
Why?
| | Phenotype | 1 | 2020 | 3162 | 0.020 |
Why?
| | Ethical Review | 1 | 2011 | 2 | 0.020 |
Why?
| | Wheelchairs | 1 | 2011 | 15 | 0.020 |
Why?
| | Paclitaxel | 1 | 2012 | 255 | 0.020 |
Why?
| | Infant, Newborn | 1 | 2022 | 6429 | 0.020 |
Why?
| | Age Distribution | 1 | 2011 | 403 | 0.020 |
Why?
| | Personal Autonomy | 1 | 2011 | 57 | 0.020 |
Why?
| | Medical History Taking | 1 | 2010 | 117 | 0.020 |
Why?
| | Disease-Free Survival | 1 | 2012 | 769 | 0.020 |
Why?
| | Personal Satisfaction | 1 | 2012 | 222 | 0.020 |
Why?
| | Drug Administration Schedule | 1 | 2012 | 779 | 0.020 |
Why?
| | Base Sequence | 1 | 1993 | 2190 | 0.020 |
Why?
| | Reference Values | 1 | 2011 | 797 | 0.020 |
Why?
| | Neoplasm Metastasis | 1 | 2012 | 688 | 0.020 |
Why?
| | Pain | 1 | 2015 | 779 | 0.020 |
Why?
| | Dementia | 1 | 2013 | 303 | 0.020 |
Why?
| | False Negative Reactions | 1 | 2009 | 60 | 0.020 |
Why?
| | Molecular Sequence Data | 1 | 1993 | 2930 | 0.020 |
Why?
| | Geriatric Assessment | 1 | 2011 | 233 | 0.020 |
Why?
| | Injury Severity Score | 1 | 2011 | 600 | 0.020 |
Why?
| | False Positive Reactions | 1 | 2009 | 121 | 0.020 |
Why?
| | Self Efficacy | 1 | 2012 | 414 | 0.020 |
Why?
| | Head and Neck Neoplasms | 1 | 1993 | 558 | 0.020 |
Why?
| | Preoperative Care | 1 | 2011 | 379 | 0.020 |
Why?
| | ROC Curve | 1 | 2009 | 614 | 0.020 |
Why?
| | Health Status | 1 | 2012 | 836 | 0.020 |
Why?
| | Survival Rate | 1 | 2011 | 2089 | 0.020 |
Why?
| | Cell Differentiation | 1 | 1993 | 2050 | 0.010 |
Why?
| | Practice Guidelines as Topic | 1 | 2013 | 1560 | 0.010 |
Why?
| | Mice | 1 | 2016 | 18339 | 0.010 |
Why?
| | Receptors, Dopamine D2 | 1 | 1996 | 93 | 0.010 |
Why?
| | Infusions, Intravenous | 1 | 1996 | 423 | 0.010 |
Why?
| | Corpus Striatum | 1 | 1996 | 179 | 0.010 |
Why?
| | Contrast Media | 1 | 1996 | 488 | 0.010 |
Why?
|
|
Brenner's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|